6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one: A Key Palbociclib Intermediate

Discover the crucial role of this high-purity intermediate in the synthesis of advanced cancer therapies.

Get a Quote & Sample

Key Advantages

Enhanced Therapeutic Efficacy

The high purity of this 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one intermediate directly contributes to the effectiveness of Palbociclib in treating various cancers.

Streamlined Synthesis Processes

As a well-defined pharmaceutical intermediate, it simplifies complex synthesis pathways for CDK4 CDK6 inhibitor drugs, reducing manufacturing challenges.

Reliable Sourcing and Quality

With a confirmed CAS 1016636-76-2 and established supply chains, manufacturers can rely on consistent quality for their fine chemical needs.

Key Applications

Pharmaceutical Manufacturing

This compound is exclusively used as a pharmaceutical intermediate in the production of Palbociclib, a targeted therapy for specific types of cancer.

Oncology Drug Development

It plays a crucial role in the synthesis of CDK4 CDK6 inhibitors, which are pivotal in modern cancer treatment protocols.

Specialty Organic Synthesis

As a complex fine chemical, it is integral to advanced organic synthesis requiring high precision and purity.

Research and Development

Used in R&D settings for exploring new synthetic routes and potential applications of related pyrido[2,3-d]pyrimidin-7(8H)-one derivatives.